Cenna Biosciences Inc.
1 clinical trials · Sponsor
◉ Watch Cenna Biosciences Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients (NCT07568041) | Cenna Biosciences Inc. | 2026-09-15 |
Track Cenna Biosciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.